BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19844990)

  • 1. Identification of molecular targets associated with transformed diffuse large B cell lymphoma using highly purified tumor cells.
    Andréasson U; Dictor M; Jerkeman M; Berglund M; Sundström C; Linderoth J; Rosenquist R; Borrebaeck CA; Ek S
    Am J Hematol; 2009 Dec; 84(12):803-8. PubMed ID: 19844990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-31 and miR-17-5p levels change during transformation of follicular lymphoma.
    Thompson MA; Edmonds MD; Liang S; McClintock-Treep S; Wang X; Li S; Eischen CM
    Hum Pathol; 2016 Apr; 50():118-26. PubMed ID: 26997445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes.
    Lossos IS; Alizadeh AA; Diehn M; Warnke R; Thorstenson Y; Oefner PJ; Brown PO; Botstein D; Levy R
    Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8886-91. PubMed ID: 12077300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transformed diffuse large B-cell lymphomas with gains of the discontinuous 12q12-14 amplicon display concurrent deregulation of CDK2, CDK4 and GADD153 genes.
    Al-Assar O; Rees-Unwin KS; Menasce LP; Hough RE; Goepel JR; Hammond DW; Hancock BW
    Br J Haematol; 2006 Jun; 133(6):612-21. PubMed ID: 16704435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas.
    Malpeli G; Barbi S; Moore PS; Scardoni M; Chilosi M; Scarpa A; Menestrina F
    Haematologica; 2004 Sep; 89(9):1091-9. PubMed ID: 15377470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust diagnosis of non-Hodgkin lymphoma phenotypes validated on gene expression data from different laboratories.
    Bhanot G; Alexe G; Levine AJ; Stolovitzky G
    Genome Inform; 2005; 16(1):233-44. PubMed ID: 16362926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of uniquely expressed transcription factors in highly purified B-cell lymphoma samples.
    Andréasson U; Edén P; Peterson C; Högerkorp CM; Jerkeman M; Andersen N; Berglund M; Sundström C; Rosenquist R; Borrebaeck CA; Ek S
    Am J Hematol; 2010 Jun; 85(6):418-25. PubMed ID: 20513119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression analysis in aggressive NHL.
    Chan WC; Huang JZ
    Ann Hematol; 2001; 80 Suppl 3():B38-41. PubMed ID: 11757704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical quantitation of diagnostic and predictive gene expression levels in follicular and diffuse large B-cell lymphoma by RT-PCR gene expression profiling.
    Sakhinia E; Glennie C; Hoyland JA; Menasce LP; Brady G; Miller C; Radford JA; Byers RJ
    Blood; 2007 May; 109(9):3922-8. PubMed ID: 17255358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma.
    González-Rincón J; Méndez M; Gómez S; García JF; Martín P; Bellas C; Pedrosa L; Rodríguez-Pinilla SM; Camacho FI; Quero C; Pérez-Callejo D; Rueda A; Llanos M; Gómez-Codina J; Piris MA; Montes-Moreno S; Bárcena C; Rodríguez-Abreu D; Menárguez J; de la Cruz-Merino L; Monsalvo S; Parejo C; Royuela A; Kwee I; Cascione L; Arribas A; Bertoni F; Mollejo M; Provencio M; Sánchez-Beato M
    PLoS One; 2019; 14(2):e0212813. PubMed ID: 30802265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An anti-apoptotic role for galectin-3 in diffuse large B-cell lymphomas.
    Hoyer KK; Pang M; Gui D; Shintaku IP; Kuwabara I; Liu FT; Said JW; Baum LG; Teitell MA
    Am J Pathol; 2004 Mar; 164(3):893-902. PubMed ID: 14982843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential development of histiocytic sarcoma and diffuse large b-cell lymphoma in a patient with a remote history of follicular lymphoma with genotypic evidence of a clonal relationship: a divergent (bilineal) neoplastic transformation of an indolent B-cell lymphoma in a single individual.
    Wang E; Papalas J; Hutchinson CB; Kulbacki E; Huang Q; Sebastian S; Rehder C; Silbermins D; Moore J; Datto M
    Am J Surg Pathol; 2011 Mar; 35(3):457-63. PubMed ID: 21317718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The feasibility of gene expression profiling generated in fine-needle aspiration specimens from patients with follicular lymphoma and diffuse large B-cell lymphoma.
    Goy A; Stewart J; Barkoh BA; Remache YK; Katz R; Sneige N; Gilles F
    Cancer; 2006 Feb; 108(1):10-20. PubMed ID: 16329118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical impact of molecular features in diffuse large B-cell lymphoma and follicular lymphoma.
    Pon JR; Marra MA
    Blood; 2016 Jan; 127(2):181-6. PubMed ID: 26447189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phospho-p70S6K/p85S6K and cdc2/cdk1 are novel targets for diffuse large B-cell lymphoma combination therapy.
    Zhao MY; Auerbach A; D'Costa AM; Rapoport AP; Burger AM; Sausville EA; Stass SA; Jiang F; Sands AM; Aguilera N; Zhao XF
    Clin Cancer Res; 2009 Mar; 15(5):1708-20. PubMed ID: 19223503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A limited role for TP53 mutation in the transformation of follicular lymphoma to diffuse large B-cell lymphoma.
    Davies AJ; Lee AM; Taylor C; Clear AJ; Goff LK; Iqbal S; Cuthbert-Heavens D; Calaminici M; Norton AJ; Lister TA; Fitzgibbon J
    Leukemia; 2005 Aug; 19(8):1459-65. PubMed ID: 15902285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma.
    Iqbal J; Neppalli VT; Wright G; Dave BJ; Horsman DE; Rosenwald A; Lynch J; Hans CP; Weisenburger DD; Greiner TC; Gascoyne RD; Campo E; Ott G; Müller-Hermelink HK; Delabie J; Jaffe ES; Grogan TM; Connors JM; Vose JM; Armitage JO; Staudt LM; Chan WC
    J Clin Oncol; 2006 Feb; 24(6):961-8. PubMed ID: 16418494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologically transformed follicular lymphoma exhibits protein profiles different from both non-transformed follicular and de novo diffuse large B-cell lymphoma.
    Ludvigsen M; Madsen C; Kamper P; Hamilton-Dutoit SJ; Bendix K; d'Amore F; Honoré B
    Blood Cancer J; 2015 Mar; 5(3):e293. PubMed ID: 25768407
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diffuse large B-cell lymphoma developed newly after 9-year remission of a follicular lymphoma].
    Hirano T; Tsuji T; Yamasaki H; Toyozumi Y; Arima N; Tsuda H
    Rinsho Ketsueki; 2016 Feb; 57(2):171-4. PubMed ID: 26935635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of MYC rearrangement in high grade B cell lymphomas: correlation of MYC immunohistochemistry and FISH analysis.
    Lynnhtun K; Renthawa J; Varikatt W
    Pathology; 2014 Apr; 46(3):211-5. PubMed ID: 24614699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.